Canada markets closed
  • S&P/TSX

    20,287.80
    -24.00 (-0.12%)
     
  • S&P 500

    4,395.26
    -23.89 (-0.54%)
     
  • DOW

    34,935.47
    -149.03 (-0.42%)
     
  • CAD/USD

    0.8019
    -0.0019 (-0.24%)
     
  • CRUDE OIL

    73.81
    +0.19 (+0.26%)
     
  • BTC-CAD

    51,225.50
    -451.24 (-0.87%)
     
  • CMC Crypto 200

    955.03
    +5.13 (+0.54%)
     
  • GOLD FUTURES

    1,816.90
    -18.90 (-1.03%)
     
  • RUSSELL 2000

    2,226.25
    -13.78 (-0.62%)
     
  • 10-Yr Bond

    1.2390
    -0.0300 (-2.36%)
     
  • NASDAQ

    14,672.68
    -105.62 (-0.71%)
     
  • VOLATILITY

    18.24
    +0.54 (+3.05%)
     
  • FTSE

    7,032.30
    -46.12 (-0.65%)
     
  • NIKKEI 225

    27,283.59
    -498.81 (-1.80%)
     
  • CAD/EUR

    0.6756
    -0.0002 (-0.03%)
     

Bellicum Pharmaceuticals: Q1 Earnings Snapshot

·1 min read

HOUSTON (AP) _ Bellicum Pharmacueticals Inc. (BLCM) on Monday reported a first-quarter loss of $11.3 million, after reporting a profit in the same period a year earlier.

On a per-share basis, the Houston-based company said it had a loss of $1.12. Losses, adjusted for non-recurring costs, were 89 cents per share.

The company's shares closed at $3.14. A year ago, they were trading at $6.11.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on BLCM at https://www.zacks.com/ap/BLCM

The Associated Press

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting